In the BioHarmony Drug Report Database

"Preview" Icon

Obeticholic acid

Ocaliva (obeticholic acid) is a small molecule pharmaceutical. Obeticholic acid was first approved as Ocaliva on 2016-05-27. It is used to treat cholangitis in the USA. It has been approved in Europe to treat biliary liver cirrhosis. The pharmaceutical is active against bile acid receptor. In addition, it is known to target nuclear receptor coactivator 2. Ocaliva’s patents are valid until 2036-04-26 (FDA).

 

Trade Name

 

Ocaliva
 

Common Name

 

obeticholic acid
 

ChEMBL ID

 

CHEMBL566315
 

Indication

 

biliary liver cirrhosis, cholangitis
 

Drug Class

 

Image (chem structure or protein)

Obeticholic acid structure rendering